Transparency, health equity, and strategies in state-based protocols for remdesivir allocation and use.
<h4>Background</h4>The Emergency Use Authorization (EUA) of remdesivir for coronavirus disease 2019 raised questions on transparency of applied strategy, and how to equitably allocate and prioritize eligible patients given limited supply of the medication. The absence of federal oversigh...
Enregistré dans:
Auteurs principaux: | Zippora Kiptanui, Sanchari Ghosh, Sabeen Ali, Karishma Desai, Ilene Harris |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a8266d8db6ee432ea9b7af4b6e7d49bd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Equity Gaps in Education: Nine Points toward More Transparency
par: Albert Ziegler, et autres
Publié: (2021) -
Evaluation of the United States COVID-19 vaccine allocation strategy.
par: Md Rafiul Islam, et autres
Publié: (2021) -
Evaluation of the United States COVID-19 vaccine allocation strategy
par: Md Rafiul Islam, et autres
Publié: (2021) -
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
par: Travis K. Warren, et autres
Publié: (2021) -
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
par: Goran Kokic, et autres
Publié: (2021)